Pre-Market Technical Breakdown Highlights on Biotech Stocks

LONDON, UK / ACCESSWIRE / June 1, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include Gilead Sciences, Baxalta, MannKind, and Sarepta Therapeutics. 

Today, ActiveWallSt.com is promoting its technical alert briefings. Get all of our alerts free by signing up to http://www.activewallst.com/register/.

The Biotech industry remains in rough waters, but investors continue to see some good prospects in this space. Let us see how the current market volatility is affecting some of the big names in the industry. Get to know these stocks better by accessing their free technical alerts at:

http://www.activewallst.com/register/

ActiveWallSt.com takes a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions.

Gilead Sciences Inc. (NASDAQ: GILD)

California-based research-based biopharmaceutical Company, Gilead Sciences Inc.’s shares gained 1.44%, closing Tuesday’s trading session at $87.06. The stock recorded a trading volume of 12.51 million shares, which was higher than its three months average volume of 10.68 million shares. The Company’s shares are trading 4.81% below their 50-day moving average. Additionally, Gilead Sciences’ stock has a Relative Strength Index (RSI) of 49.71.

Baxalta Inc. (NYSE: BXLT)

Illinois headquartered biopharmaceutical Company, Baxalta Inc., is a developer, manufacturer, and marketer of an assortment of products largely for the treatment of hemophilia, immunology, and oncology globally. On Tuesday, shares in the Company recorded a trading volume of 15.42 million shares, which was above their three months average volume of 10.93 million shares. The stock saw a slight correction of 0.66%, ending the day at $45.23. The Company’s shares have advanced 7.82% in the last month, 14.91% in the previous three months, and 16.09% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 8.68% and 19.50%, respectively. Furthermore, shares of Baxalta have an RSI of 67.25.

MannKind Corp. (NASDAQ: MNKD)

Valencia, California headquartered biopharmaceutical Company, MannKind Corp.’s stock finished the day at $0.95, which was a correction of 2.16%. A total volume of 5.53 million shares was traded. The Company’s shares are trading below their 50-day moving average by 33.66%. Additionally, shares of MannKind have an RSI of 36.03. On May 10th, 2016, the Company’s stock received reiteration of their previous ratings from the following research firms Piper Jaffray, and RBC Capital Markets which were ‘Underweight’, and ‘Underperform’, respectively.

Sarepta Therapeutics Inc. (NASDAQ: SRPT)

Eteplirsen’s manufacturer and biopharmaceutical Company, Sarepta Therapeutics Inc.’s shares ended yesterday’s session 1.23% lower at $20.93. The stock recorded a trading volume of 6.85 million shares, which was above its three months average volume of 6.44 million shares. The Company’s shares have advanced 47.50% in the last one month and 52.66% in the previous three months. The stock is trading 12.05% above its 50-day moving average. Moreover, shares of Sarepta Therapeutics have an RSI of 57.34. On May 3rd, 2016, research firm Leerink Partners downgraded the Company’s stock rating from ‘Market Perform’ to ‘Underperform’. SRPT free technical alert is just a click away at:

http://www.activewallst.com/register/

—

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 440621